Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD47 combination therapy

Anti-CD47 combination therapy

US Patent 12258401 · Granted Mar 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD47 combination therapy2023
Anti-CD47 combination therapy2023
Anti-CD47 combination therapy2023
Combination of lenalidomide and polypeptide construct, and uses thereof2022
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B2021
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B2021
Fusions of antibodies to CD38 and attenuated interferon alpha2021
Fusions of antibodies to CD38 and attenuated interferon alpha2021
Combination of lenalidomide and polypeptide construct, and uses thereof2019
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B2018
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B2018
Antibodies2018